Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2025-12-25 @ 2:56 AM
NCT ID:
NCT03162133
Eligibility Criteria:
Inclusion Criteria:
* Have been diagnosed as stage I to III breast cancer 0.5 to 4.0 years before enrollment
* Taking an AI (aromatase inhibitors )，and had been receiving an AI for at least 6 months
Exclusion Criteria:
* A prior history of breast or any other cancer except basal or squamous cell skin cancer Inflammatory breast cancer
* With exercise contraindications：chronic obstructive pulmonary disease, uncontrolled hypertension, evidence of liver or kidney failure, symptomatic ischemic heart disease ,conditions involving the immune system such as autoimmune and/or inflammatory diseases, cognitive impairment, alcohol/drug abuse
* Current Baduanjin practice (within the last 6 months), and/or previous Baduanjin practice for more than 3 months
* Women reporting 5 hours or more of vigorous physical activity per week
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03162133
Study Brief:
Protocol Section:
NCT03162133